E
ProPhase Labs, Inc. PRPH
$0.3396 -$0.0107-3.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -421.62% -7.05% 1.79% 28.41% -70.22%
Total Depreciation and Amortization -75.54% 44.94% -3.73% 4.97% -10.14%
Total Amortization of Deferred Charges -21.65% 163.40% 60.96% 317.14% -33.96%
Total Other Non-Cash Items 1,390.76% -14.40% -49.87% 12.76% 34.52%
Change in Net Operating Assets 1,716.53% 12.29% 40.02% -147.75% 296.78%
Cash from Operations 11.39% 16.36% 5.88% -579.81% 83.82%
Capital Expenditure 233.52% -576.92% 97.23% -292.89% 64.22%
Sale of Property, Plant, and Equipment -100.00% -47.33% -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -100.00% 415.03% -207.10%
Cash from Investing 58.76% -178.23% -94.91% 292.64% -480.72%
Total Debt Issued -65.79% 217.19% -42.76% -- --
Total Debt Repaid -8.14% -127.08% -275.13% -- --
Issuance of Common Stock -- -100.00% -- -- -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 30.78% -46.35% 134.39% -22.33% 143.67%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 109.76% -302.07% 252.30% -145.53% 129.05%